BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1706752)

  • 1. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.
    Colombo MP; Ferrari G; Stoppacciaro A; Parenza M; Rodolfo M; Mavilio F; Parmiani G
    J Exp Med; 1991 Apr; 173(4):889-97. PubMed ID: 1706752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells.
    Colombo MP; Lombardi L; Stoppacciaro A; Melani C; Parenza M; Bottazzi B; Parmiani G
    J Immunol; 1992 Jul; 149(1):113-9. PubMed ID: 1376745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.
    Stoppacciaro A; Melani C; Parenza M; Mastracchio A; Bassi C; Baroni C; Parmiani G; Colombo MP
    J Exp Med; 1993 Jul; 178(1):151-61. PubMed ID: 7686211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
    Stoppacciaro A; Forni G; Colombo MP
    Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors.
    Colombo MP; Lombardi L; Melani C; Parenza M; Baroni C; Ruco L; Stoppacciaro A
    Am J Pathol; 1996 Feb; 148(2):473-83. PubMed ID: 8579110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells.
    Lechanteur C; Moutschen M; Princen F; Lopez M; Franzen E; Gielen J; Bours V; Merville MP
    Cancer Gene Ther; 2000 May; 7(5):676-82. PubMed ID: 10830715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.
    Qin H; Chatterjee SK
    Hum Gene Ther; 1996 Oct; 7(15):1853-60. PubMed ID: 8894677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice.
    Kim JS; Son Y; Bae MJ; Lee M; Lee CG; Jo WS; Kim SD; Yang K
    Oncol Rep; 2015 Jul; 34(1):147-54. PubMed ID: 25976379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
    Gunji Y; Tagawa M; Matsubara H; Takenaga K; Shimada H; Kondo F; Suzuki T; Nakajima K; Sugaya M; Asano T; Ochiai T; Isono K; Horitsu K; Kageyama H; Nakamura Y; Sakiyama S
    Cancer Lett; 1996 Mar; 101(2):257-61. PubMed ID: 8620478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
    Obermueller E; Vosseler S; Fusenig NE; Mueller MM
    Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
    Tasaki K; Gunji Y; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Kouzu T; Sakiyama S; Tagawa M
    Anticancer Res; 1998; 18(3A):1453-6. PubMed ID: 9673355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice.
    Chang JM; Metcalf D; Gonda TJ; Johnson GR
    J Clin Invest; 1989 Nov; 84(5):1488-96. PubMed ID: 2478588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice.
    Nakashima E; Oya A; Kubota Y; Kanada N; Matsushita R; Takeda K; Ichimura F; Kuno K; Mukaida N; Hirose K; Nakanishi I; Ujiie T; Matsushima K
    Pharm Res; 1996 Dec; 13(12):1896-901. PubMed ID: 8987092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The v-src oncogene blocks the differentiation of a murine myeloid progenitor cell line and induces a tumorigenic phenotype.
    Krüger A; Anderson SM
    Oncogene; 1991 Feb; 6(2):245-56. PubMed ID: 1705687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
    Dranoff G; Jaffee E; Lazenby A; Golumbek P; Levitsky H; Brose K; Jackson V; Hamada H; Pardoll D; Mulligan RC
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3539-43. PubMed ID: 8097319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine.
    Mahvi DM; Burkholder JK; Turner J; Culp J; Malter JS; Sondel PM; Yang NS
    Hum Gene Ther; 1996 Aug; 7(13):1535-43. PubMed ID: 8864754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
    Jie JZ; Wang JW; Qu JG; Hung T
    World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.